醫師學術論文
Paper蕭博任 Po-Jen Hsiao 主治醫師
蕭博任醫師於中國醫藥大學附設醫院泌尿部接受完整的住院醫師訓練,且參加國際性腹腔鏡研習手術訓練,專長在血尿、阻塞性尿路病變、急性尿滯留、泌尿系統創傷、男性不孕症、泌尿腫瘤內視鏡及微創手術、結石、排尿障礙、泌尿道感染等。
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 蕭博任(Po-Jen Hsiao)、(Chih-Da Wu)、(Pei-Yi Wong)、(Mu-Chi Chung)、楊玉婉(Yu-Wan Yang)、(Laing-You Wu)、(Kai-Yu Hsiao)、鍾季容(Chi-Jung Chung)*,APOE-ε4 alleles modify the decline of MMSE scores associated with time-dependent PM2.5 exposure: Findings from a Community-based Longitudinal Cohort Study,AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY,2024 Sep,32(9):1080-1092 | 2024 . 09 |
2 | 曾浩翔(CHEN HAO XIANG)、蔡禮賢(Li-Hsien,Tsai)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、林精湛(Ching-Chan Lin)、林哲弘(Che-Hung Lin)、葉士芃(Shih-Peng Yeh)、連啟舜(Chi-Shun Lien)、楊啟瑞(Chi-Rei Yang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、謝博帆(Hsieh, Po-Fan)*、黃志平(Chi-Ping Huang)*,Enzalutamide prior to radium-223 is associated with better overall survival in metastatic castration-resistant prostate cancer patients compared to abiraterone - a retrospective study,Cancers,2023 Jul,15(13):3516-3516 | 2023 . 07 |
3 | (Mu-Chi Chung)、(Peir-Haur Hung)、蕭博任(Po-Jen Hsiao)、(Laing-You Wu)、張兆祥(Chao-Hsiang Chang)、(Kai-Yu Hsiao)、(Ming-Ju Wu)、(Jeng-Jer Shieh)、黃毓銓(Huang, Yu-Chuen)*、鍾季容(Chi-Jung Chung)*,Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan,JAMA Network Open,2023 Feb,6(2):e230453 | 2023 . 02 |
4 | 賴俊佑(Chun-Yo Laih)、蕭博任(Po-Jen Hsiao)、謝博帆(Hsieh, Po-Fan)、王又德(Yu-De Wang)、賴俊鳴(Chun-Ming Lai?)、楊朝棟(Chao-Tung Yang)、林祝興(Chu-Hsing Lin)、黃志平(Chi-Ping Huang)*,QSOFA and SOFA scores are valuable tools for predicting postoperative sepsis resulting from ureteroscopic lithotripsy (URSL),MEDICINE,2022 Oct,0(): | 2022 . 10 |
5 | 方仁愷(Fang Jen Kai)、蕭博任(Po-Jen Hsiao)、邱鴻傑(Hung-Chieh Chiu)、黃志平(Chi-Ping Huang)*,Robot-Assisted Anatrophic Nephrolithotomy for complete staghorn stone,MEDICINE,2022 Jul,(): | 2022 . 07 |
6 | 方仁愷(Fang Jen Kai)、蕭博任(Po-Jen Hsiao)、邱鴻傑(Hung-Chieh Chiu)、黃志平(Chi-Ping Huang)*,Robot-Assisted Anatrophic Nephrolithotomy for complete staghorn stone,MEDICINE,2022 Jul,(): | 2022 . 07 |
7 | (Mu-Chi Chung)、許惠悰(Hui-Tsung Hsu)、張兆祥(Chao-Hsiang Chang)、(Peir-Haur Hung)、蕭博任(Po-Jen Hsiao)、吳亮佑(Wu, Liang-You)、(Ming-Ju Wu)、(Jeng-Jer Shieh)、鍾季容(Chi-Jung Chung)*,Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis,Scientific Reports,2022 Jun,12():10147 | 2022 . 06 |
8 | 許惠悰(Hui-Tsung Hsu)、(Hui-Ling Lee)、(Hsu-Hui Cheng)、張兆祥(Chao-Hsiang Chang)、劉秋松(LIU, CHIU-SHONG)、蕭博任(Po-Jen Hsiao)、張菡(Han Chang)、連啟舜(Chi-Shun Lien)、(Mu-Chi Chung)、鍾季容(Chi-Jung Chung)*,Relationships of multiple metals exposure, global DNA methylation, and urothelial carcinoma in central Taiwan,ARCHIVES OF TOXICOLOGY,2022 Mar,0():0 | 2022 . 03 |
9 | (Mu-Chi Chung,)、(Peir-Haur Hung)、蕭博任(Po-Jen Hsiao)、(Laing-You Wu)、(Chao-Hsiang Chang)、(Ming-Ju Wu)、(Jeng-Jer Shieh)、鍾季容(Chi-Jung Chung)*,Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan,JAMA Network Open,2021 Nov,4(11):e2135353 | 2021 . 11 |
10 | 莊伯恒(Po-Heng Chuang)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)*、鄒頡龍(Chieh-Lung Chou)*,Diagnostic potential of Low Serum Platelet, Albumin and prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis,Journal of Clinical Medicine,2021 Jun,(): | 2021 . 06 |
11 | 黃志平(Chi-Ping Huang)、張兆祥(Chao-Hsiang Chang)、吳錫金(Hsi-Chin Wu)、楊啟瑞(Chi-Rei Yang)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、王又平(Yu-Ping Wang)、王又德(Yu-De Wang)*,External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomy,BMC Urology,2020 Sep,20(1):146 | 2020 . 09 |
12 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、黃志平(Chi-Ping Huang)、吳錫金(Hsi-Chin Wu)、謝博帆(Po-Fan Hsieh)*、鄒頡龍(Chieh-Lung Chou)*,A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients,Toxins,2020 Jun,12(6):365-365 | 2020 . 06 |
13 | 李聖偉(Sheng-Wei Li)、蕭博任(Po-Jen Hsiao)*、張兆祥(Chao-Hsiang Chang)、鄒頡龍(Chieh-Lung Chou),Lower urinary tract symptoms associated with Double-J stent,Urological Science,2019 May,30(3):92-98 | 2019 . 05 |
14 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、黃志平(Huang, Chi-Ping)*、沈德群(Te-Chun Shen)*,A Huge Cavity in the Right Upper Abdomen,BRITISH JOURNAL OF HOSPITAL MEDICINE,2019 Mar,80(3):173-173 | 2019 . 03 |
15 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、林精湛(Ching-Chan Lin)*、張兆祥(Chang,Chao-Hsiang)、葉士芃(Su-Peng Yeh),Outcomes of Stage II to IV Upper Tract Urothelial Carcinoma and Adjuvant Chemotherapy for Localized Advanced cancer,Oncology Letters,2019 Jan,17(1):1341-1348 | 2019 . 01 |
16 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、黃志平(Chi-Ping Huang)、陳汶吉(Wen-Chi Chen)、葉進仲(Chin-Chung Yeh)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Kuo-Liang Chen)、連啟舜(Chi-Shun Lien)、陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、吳錫金(Hsi-Chin Wu)*,Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4e10 ng/mL,KAOHSIUNG JOURNAL OF MEDICAL SCIENCES,2018 Aug,34():461-466 | 2018 . 08 |
17 | 陳冠亨(Guang-Heng Chen)、王曦賢(Hsi-Hsien Wang)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、李聖偉(Sheng-Wei Li)、黃志平(Huang, Chi-Ping)、葉進仲(Yeh, Chin-Chung)、張兆祥(Chang, Chao-Hsiang)*,Evaluation of the relationship and postoperative glomerular filtration rate between the living donor and the recipients in kidney transplantation,Urological Science,2017 Dec,28(4):227-231 | 2017 . 12 |
18 | 張議徽(Yi-Huei Chang)、蕭子玄(SIU JUSTIN JI-YUEN)、蕭博任(Po-Jen Hsiao)、張兆祥(Chang, Chao-Hsiang)、鄒頡龍(Chou, Chieh-Lung)*,Review of underactive bladder,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2017 Sep,(): | 2017 . 09 |
19 | 蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、鄒頡龍(Chieh-Lung Chou)*、賴學洲(Hsueh-Chou Lai)*、彭成元(Cheng-Yuan Peng)、蘇冠賓(Kuan-Pin Su),Anti-viral therapy and decreased sexual desire in patients with chronic hepatitis C,PLoS One,2016 Aug,11(8): | 2016 . 08 |
20 | 蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張議徽(Yi-Huei Chang)、張兆祥(Chang,Chao-Hsiang)*、張菡(Han Chang)、白禮源(Li-Yuan Bai),An unresectable retroperitoneal malignant fibrous histiocytoma: a case report,Oncology Letters,2016 Apr,11(4):2403-2407 | 2016 . 04 |
21 | 蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、黃志平(Chi-Ping Huang)*,Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients,RENAL FAILURE,2016 Mar,38(5):663-670 | 2016 . 03 |
22 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、張兆祥(Chang,Chao-Hsiang)、陳汶吉(Chen, Wen-Chi)、葉進仲(Yeh, Chin-Chung)、黃志平(Chi-Ping Huang)*、鍾季容(Chi-Jung Chung)、鄒頡龍(Chieh-Lung Chou)、陳國樑(Chen, Kuo-Liang),Economic fluctuation affects vasectomy utilization: A single-institution study,Urological Science,2015 Sep,26(3):214-217 | 2015 . 09 |
23 | 張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、陳冠亨(Guang-Heng Chen)、黃志平(Chi-Ping Huang)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、張兆祥(Chang,Chao-Hsiang)*,The value of cystography in the prediction of early urinary continence after radical prostatectomy,Urological Science,2015 Aug,(): | 2015 . 08 |
24 | 陳冠亨(Guang-Heng Chen)、蕭博任(Po-Jen Hsiao)、張議徽(Yi-Huei Chang)、陳至正(Chi-Cheng Chen)、吳錫金(Wu,Hsi-Chin)、楊啟瑞(Che-Rei Yang)、陳國樑(Chen, Kuo-Liang)、鄒頡龍(Chieh-Lung Chou)、陳汶吉(Chen, Wen-Chi)、張兆祥(Chang,Chao-Hsiang)*,Spontaneous ureteral rupture and review of the literature,AMERICAN JOURNAL OF EMERGENCY MEDICINE,2014 Jul,32(7):772-774 | 2014 . 07 |
25 | 謝博帆(Po-Fan Hsieh)、張兆祥(Chang,Chao-Hsiang)、連啟舜(Chi-Shun Lien)、吳錫金(Wu,Hsi-Chin)、蕭博任(Po-Jen Hsiao)、鄒頡龍(Chieh-Lung Chou)*,Remote monitoring of videourodynamics using smart phone and free instant messaging software,NEUROUROLOGY AND URODYNAMICS,2013 Jul,(): | 2013 . 07 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | A Case report of Ipsilateral Synchronous Acquired Cystic Disease-Associated Renal Cell Carcinoma and Unclassified Renal cell Carcinoma,2024 台灣泌尿科醫學會年會,林口長庚醫院長庚國際會議中心,2024.08.16~2024.08.18, | 2024 . 08 |
2 | 腎臟移植後出現腔室症候群的案例分析,2023台灣內科醫學會會員大會暨學術演講會,台大醫院國際會議中心,2023.12.02~2023.12.03, | 2023 . 12 |
3 | 腎移植後腔室症候群的個案分析及文獻回顧,台灣移植醫學學會2023移植年會暨教育訓練課程暨第二屆台韓交流論壇暨第三屆亞洲胰臟及胰島細胞移植學會會議,台北南港展覽館二館七樓,2023.12.09~2023.12.10, | 2023 . 12 |
4 | The role of SPARE nephrometry and tumor contact surface area in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,第110屆日本泌尿外科醫協會年會 (JUA),日本神戶,2023.04.20~2023.04.23, | 2023 . 04 |
5 | 台灣的腎臟移植患者注射新冠肺炎疫苗的效度分析,2022台灣移植醫學會年會,南港展覽館,2022.12.10~2022.12.11, | 2022 . 12 |
6 | 未打COVID19疫苗的腎移植病人確診後抗體反應仍不佳,2022台灣內科醫學會會員大會暨學術演講,台大醫院國際會議中心,2022.12.03~2022.12.04, | 2022 . 12 |
7 | HCV陰性的腎臟受贈者於接受HCV陽性的大愛腎臟移植術後三小時HCV病毒呈陽性-口服直接抗病毒藥應考慮即早使用,2022台灣移植醫學會年會,南港展覽館,2022.12.10~2022.12.11, | 2022 . 12 |
8 | Improvement on semen parameter in infertile varicocele patients receiving microscopic varicocelectomy compared with conventional varicocelectomy,2022 台灣泌尿科醫學會年會-國際會議ISTUA,高雄萬豪酒店,2022.08.20~2022.08.21, | 2022 . 08 |
9 | ,童綜合醫院50週年系列演講-達文西手術Young Talent Session(二),童綜合醫療社團法人童綜合醫院,2022.05.28~2022.05.28,Prostate Cancer mHSPC Combination Therapy | 2022 . 05 |
10 | Radium-223 for mCRPC: Real-world experience of a single-center,2021 台灣泌尿科醫學會年會,台中榮總,2021.12.25~2021.12.26, | 2021 . 12 |
11 | ,110 年泌尿科醫學會中區學術討論會,秀傳醫療社團法人秀傳紀念醫院【南平大樓九樓會議室】,2021.11.20~2021.11.20,Profound changes that PARP inhibitors brings to metastatic castration-resistant prostatic cancer(mCRPC) | 2021 . 11 |
12 | A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients,第十五屆泛太平洋尿控學會年會the 15th pan-pacific continence society meeting,高雄萬豪酒店(與日本視訊會議),2021.09.11~2021.09.12, | 2021 . 09 |
13 | The role of tumor contact surface area and SPARE nephrometry in predicting malignancy and aggressiveness of clinical T1 tumors treated with partial nephrectomy,2022 International Session of TUA Conference,高雄醫學大學,2020.08.20~2020.08.20, | 2020 . 08 |
14 | Can donor Tc-99m diethylene triamine pentaacetic acid renal scan predict graft function recovery in living donor kidney transplant?,TUA 2020,台灣大學國際會議中心,2020.08.21~2020.08.23, | 2020 . 08 |
15 | Neoadjuvant chemotherapy and adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma,台灣泌尿科醫學會年會,台大,2020.08.21~2020.08.23, | 2020 . 08 |
16 | Dual Kidney Transplantation: the Renal Graft Function Will Improve, Just Like a Sleeping Beauty Worth Waiting for,第三屆全球華人腎臟病學術大會,南京國際青年文化中心,2019.12.05~2019.12.08, | 2019 . 12 |
17 | Peripheral CD4 and CD8 Counts as guidance for Anti-ThymoGlobulin Dosage in Kidney Transplantation—A proposed new approach,Asia Pacific AKI to/on CKD Summit in conjunction with 台灣腎臟醫學會108年會員大會暨學術演講會,台大國際會議中心,2019.11.22~2019.11.24, | 2019 . 11 |
18 | Outcome of lymph node dissection in renal pelvis urothelial carcinoma,台灣泌尿科醫學會年會,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
19 | ABO血型不相容活體腎臟移植-中國醫藥大學附設醫院經驗,109年台灣泌尿科醫學會年會,中國醫藥大學,2019.08.16~2019.08.18, | 2019 . 08 |
20 | Adjuvant chemotherapy in T3/T4 upper urinary tract urothelial carcinoma—CMUH experience,台灣泌尿科醫學會年會國際場 ISTUA,中國附醫,2019.08.16~2019.08.18, | 2019 . 08 |
21 | predictive markers for the prognosis of muscle invasive bladder cancer treated with neoadjuvant chemotherapy,泌尿科醫學會年會,高雄長庚,2017.08.19~2017.08.20, | 2017 . 08 |
22 | Comparison of Treatment of Large Proximal Ureteral Stones Laparoscopic Ureterolithotomy Versus Percutaneous Nephrolithotomy Versus Ureteroscopic Lithotripsy,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.08~2016.11.12,URS outcomes | 2016 . 11 |
23 | Experience of partial cystectomy in bladder urothelial cancer,WCE 2016,The Cape Town International Convention Centre, Cape Town, South Africa,2016.11.08~2016.11.12,Oncology: Miscellaneous-Surgical outcomes | 2016 . 11 |
24 | Anti-viral therapy and decreased sexual desire in patients with chronic hepatitis C,2016 Taiwan Digestive Disease Week,台大醫學院國際會議中心,2016.09.30~2016.10.02, | 2016 . 09 |
25 | Robot-Assisted Anatrophic Nephrolithotomy for complete staghorn stone: case series in China Medical University Hospital,104th Annual Meeting of the Japanese Urological Association,Sendai,2016.04.23~2016.04.25,Urolithiasis | 2016 . 04 |
26 | The concordance between pre-operative MRI and pathology stage in patients with prostate cancer underwent prostatectomy in CMUH,103rd Annual Meeting of the Japanese Urological Association,Kanazawa,2015.04.18~2015.04.21,Prostate cancer diagnosis | 2015 . 04 |
27 | PRIMARY ADRENAL INSUFFICIENCY WITH BILATERAL ADRENAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台北國際會議中心,2014.09.06~2014.09.07, | 2014 . 09 |
28 | Robotic assist rectal GIST resection with radical prostatectomy,32屆世界泌尿內視鏡醫學大會32nd World Congress of Endourology and SWL(WCE 2014),台北國際會議中心,2014.09.03~2014.09.07, | 2014 . 09 |
29 | ,第24第一次外會員代表大會暨第73次學術演講會(103年度外科聯合學術演講會),台北榮民總醫院,2014.03.15~2014.03.16,C型肝炎使用干擾素治療與性功能障礙之研究 | 2014 . 03 |
30 | 使用智慧型手機以及免費通訊軟體即時監控影像尿路動力學-運用於住院醫師教學,102年度標竿學習研討會 第三屆教學優良既教學創新成果經驗分享,中國醫藥大學安康大樓五樓教學部會議室(一),2013.11.09~2013.11.09,教學創新經驗分享 | 2013 . 11 |
31 | ,第18屆第2次會員大會暨第35次學術研討會,義守大學燕巢校區,2013.08.31~2013.09.01,Remote Monitoring of VideourodynamicsUsing Smart Phone and Free Instant Messaging Software | 2013 . 08 |
32 | MANAGEMENT OF ENCASEMED AORTA AND INFERIOR VENA CAVA TO THE RETROPERITONEAL TUMOR: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.17~2012.08.18, | 2012 . 08 |
33 | THE INITIAL MANIFESTATION OF RENAL CELL CARCINOMA IS PULMONARY EMBOLISM: A CASE REPORT,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.17~2012.08.18, | 2012 . 08 |
34 | THE MUTUAL EFFECTS BETWEEN RENAL TRAUMA AND URETERAL STONE,台灣泌尿科醫學會年會,台大醫院國際會議中心,2012.08.17~2012.08.18, | 2012 . 08 |
35 | METACHRONOUS CANCER OF THE HEAD AND NECK AND THE URINARY TRACT,台灣泌尿科醫學會年會,台南成大醫學院,2011.08.13~2011.08.14, | 2011 . 08 |
36 | MENINGITIS-RETENTION SYNDROME: A CASE REPORT,台灣泌尿科醫學會年會,台南成大醫學院,2011.08.13~2011.08.14, | 2011 . 08 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 臨床試驗與研究計畫,CMUH106-REC2-099,葉士芃(Yeh, Su-Peng)、吳錫金(Wu, Hsi-Chin)、張議徽(Yi-Huei Chang)、楊啟瑞(Yang, Che-Rei)、蕭博任(Po-Jen Hsiao)、謝博帆(Po-Fan Hsieh)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、林哲弘(Che-Hung Lin)、林精湛(Ching-Chan Lin)、林維卿(Lin, Wei-Ching),附醫廠商計畫,一項隨機分配、雙盲、第2期試驗,評估腎細胞癌在接受一種血管內皮生長因子(VEGF)標靶治療後,使用二種不同起始劑量Lenvatinib (18mg相較於14mg QD)合併Everolimus (5mg QD)之安全性和療效,2017.1.1~2017.12.31 | 2017 . 01 |
2 | 臨床試驗與研究計畫,CMUH106-REC2-121,吳錫金(Wu, Hsi-Chin)、楊啟瑞(Yang, Che-Rei)、陳冠亨(Guang-Heng Chen)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、張議徽(Yi-Huei Chang)、蕭博任(Po-Jen Hsiao)、葉士芃(Yeh, Su-Peng)、林哲弘(Che-Hung Lin),附醫廠商計畫,PARACHUTE:Pazopanib治療各種狀況晚期腎細胞癌患者之臨床療效及安全性實務評估;一項前瞻性、非介入性、觀察性研究,2017.1.1~2017.12.31 | 2017 . 01 |